Maryland-Based Life Sciences Firm Scores Early Exit as Eli Lilly and Company Acquires CrossBridge Bio for Up to $300M
Linden Lake Labs (L3), a Rockville-based life sciences platform, operating largely under stealth since its 2024 launch, notches a seed-to-exit win in under 18 months – while quietly building what could become Maryland's next major biologics infrastructure platform.